Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus dexmedetomidine target-controlled infusion for post-liver transplant sedation
PACTR202503518380400Phase 4Recruiting
- Sponsor
- National Liver Institute
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and dexmedetomidine in None (2 arms), sponsored by National Liver Institute. Primary endpoint: Mean arterial blood pressure. Started Jun 2024; status: recruiting.
02
Drugs
propofoldexmedetomidine
Beyond the preview
Go deeper on PACTR202503518380400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503518380400.